Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis

被引:11
作者
Liu, Yuan [1 ]
Vela, Monica [1 ,2 ]
Rudakevych, Tanya [3 ,4 ]
Wigfield, Christopher [5 ]
Garrity, Edward [5 ]
Saunders, Milda R. [4 ]
机构
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Stat, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA
[5] Univ Chicago, Lung Transplant Program, Chicago, IL 60637 USA
关键词
cystic fibrosis; lung transplarit; pulmonary fibrosis; waitlist; access to healthcare; socioeconomic factors; SYSTEMIC-LUPUS-ERYTHEMATOSUS; UNITED-STATES; INTERNATIONAL-SOCIETY; SELECTION; CANDIDATES; OBESITY; ACCESS; HEART; DISPARITIES; OUTCOMES;
D O I
10.1016/j.healun.2016.08.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Since 2005, the Lung Allocation Score (LAS) has prioritized patient benefit and post transplant survival, reducing waitlist to transplant time to <200 days and decreasing mortality on the waitlist. A current challenge is the wait for the waitlist the time between the patient's transplant eligible diagnosis and waitlist registration. METHODS: We investigated whether sociodemographic (age, sex, race, insurance, marital status, median household income) and clinical (forced expiratory volume in 1 second [FEV1] percent of predicted, body mass index, depression/anxiety, alcohol/substance misuse, absolute/relative contraindications) factors influenced referral and waitlist registration. We conducted a retrospective cohort study through chart review of hospitalized patients on the University of Chicago general medicine service from 2006 to 2014 who met transplant-eligible criteria and ICD-9 billing codes for cystic fibrosis (CF) and pulmonary fibrosis (PF). We analyzed the times from transplant eligibility to referral, work-up and waitlisting using Kaplan-Meier curves and log-rank tests. RESULTS: Overall, the referral rate for transplant-eligible patients was 64%. Of those referred, approximately 36% reach the lung transplant waitlist. Referred CF patients were significantly more likely to reach the transplant waitlist than PF patients (CF 60% vs PF 22%, p < 0.05). In addition, CF patients had a shorter wait from transplant eligibility to waitlist than PF patients (329 vs 2,369 days, respectively [25th percentile], p < 0.05). Patients with PF and CF both faced delays from eligibility to referral and waitlist. CONCLUSIONS: Quality improvement efforts are needed to better identify and refer appropriate patients for lung transplant evaluation. Targeted interventions may facilitate more efficient evaluation completion and waitlist appearance. (C) 2017 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 50 条
  • [21] Risks associated with lung transplantation in cystic fibrosis patients
    Li, Susan S.
    Tumin, Dmitry
    Krone, Katie A.
    Boyer, Debra
    Kirkby, Stephen E.
    Mansour, Heidi M.
    Hayes, Don, Jr.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (11) : 893 - 904
  • [22] Incorporating patient and caregiver feedback into lung transplant referral guidelines for individuals with cystic fibrosis-Preliminary findings from a novel paradigm
    Smith, Patrick J.
    Dunitz, Jordan M.
    Lucy, Amy
    Hempstead, Sarah E.
    Tallarico, Erin
    Faro, Albert
    Pilewski, Joseph M.
    Ramos, Kathleen J.
    CLINICAL TRANSPLANTATION, 2020, 34 (10)
  • [23] Lung transplant in patients with familial pulmonary fibrosis
    Bennett, David
    Fossi, Antonella
    Lanzarone, Nicola
    De Vita, Elda
    Luzzi, Luca
    Paladini, Piero
    Bargagli, Elena
    Rottoli, Paola
    Sestini, Piersante
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (06) : 1 - 9
  • [24] Nocardia farcinica lung infection in a patient with cystic fibrosis and a lung transplant
    Chacon, C. F.
    Vicente, R.
    Ramos, F.
    Porta, J.
    Lopez Maldonado, A.
    Ansotegui, E.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2015, 62 (03): : 161 - 164
  • [25] Lung Transplant in Idiopathic Pulmonary Fibrosis
    George, Timothy J.
    Arnaoutakis, George J.
    Shah, Ashish S.
    ARCHIVES OF SURGERY, 2011, 146 (10) : 1204 - 1209
  • [26] A review of nutritional problems and the cystic fibrosis lung transplant patient
    Dosanjh, A
    PEDIATRIC TRANSPLANTATION, 2002, 6 (05) : 388 - 391
  • [27] Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the US Cystic Fibrosis Foundation Patient Registry
    Sears, Edmund H., Jr.
    Hinton, Alexandra C.
    Lopez-Pintado, Sara
    Lary, Christine W.
    Zuckerman, Jonathan B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (09) : 1250 - 1257
  • [28] Endobronchial Pseudallescheria boydii in Lung Transplant Patient With Cystic Fibrosis
    Shah, Sonia S.
    Karnak, Demet
    Budev, Marie
    Avery, Robin K.
    Mehta, Atul C.
    JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2007, 14 (01) : 48 - 50
  • [29] Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis
    Choi, Kevin J.
    Cheng, Tracy Z.
    Honeybrook, Adam L.
    Gray, Alice L.
    Snyder, Laurie D.
    Palmer, Scott M.
    Hachem, Ralph Abi
    Jang, David W.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (03) : 389 - 393
  • [30] An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry
    Benden, Christian
    Goldfarb, Samuel B.
    Stehlik, Josef
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (11) : 1162 - 1169